Status:
COMPLETED
Quantum Molecular Resonance Electrotherapy in Severe Dry Eye Disease
Lead Sponsor:
Centro Oculistico Borroni
Conditions:
Dry Eye
Eligibility:
All Genders
Phase:
NA
Brief Summary
To evaluate the efficacy and safety of Quantum Molecular Resonance (QMR) treatment in patients with severe dry eye disease (DED), as well as its effects on aqueous-deficient (ADDE), evaporative (EDE) ...
Detailed Description
To evaluate the efficacy and safety of Quantum Molecular Resonance (QMR) treatment in patients with severe dry eye disease (DED), as well as its effects on aqueous-deficient (ADDE), evaporative (EDE) ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \> 18 years old with a self-reported history of DED
- OSDI score ≥ 33 points
- TBUT less than 10 seconds.
- Exclusion criteria:
- skin pathologies that prevent QRM treatment
- corneal infection and corneal dystrophies
- active ocular allergies
- intraocular surgery or laser ocular surgery
Exclusion
Key Trial Info
Start Date :
November 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2023
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT06119386
Start Date
November 3 2022
End Date
February 25 2023
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Oculistico Borroni
Gallarate, VA, Italy, 21013